Savara IncSVRA

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$5.07
Market cap
$1.0B
P/E
—
Revenue (TTM)
—
Net income
-$139.3M
Dividend yield
—
1-year total return
46.1%
Net margin
—
Revenue growth
—
Debt / equity
0.21x

What Savara Inc does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$257,000—————
Net income-$49.6M-$43.0M-$38.1M-$54.7M-$95.9M-$118.8M
Free cash flow-$39.9M-$40.1M-$34.6M-$51.4M-$89.1M-$101.1M

More on SVRA.

Figures from Savara Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.